Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyn Morice

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Eclinicalmedicine|August 4, 2023
Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysisZiwen Zheng, Junfeng Huang, Ziyuan Xiang, et al.
ERJ Open Research|May 25, 2023
Improving asthma care through implementation of the SENTINEL programme: findings from the pilot siteMichael G Crooks, Lucia Crowther, Helena Cummings, et al.
The European Respiratory Journal|May 14, 2021
Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a studyAlyn Morice, Jaclyn A Smith, Lorcan McGarvey, et al.
Thorax|March 13, 2026
Aligning management of chronic cough in asthma with BTS/NICE/SIGN guidancePaul Marsden, Jaclyn Ann Smith, Surinder S Birring, et al.
Thorax|December 13, 2023
British Thoracic Society Clinical Statement on chronic cough in adultsSean M Parker, Jaclyn Ann Smith, Surinder S Birring, et al.
Lung|December 13, 2022
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic CoughLorcan McGarvey, Jaclyn A Smith, Alyn Morice, et al.
ERJ Open Research|August 5, 2021
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic coughValerie J Ludbrook, Kate E Hanrott, James L Kreindler, et al.
Breathe (Sheffield, England)|April 16, 2026
Find your career: the ERS "My Career Path" seriesSachin Ananth, Joachim Aerts, Sanjay H Chotirmall, et al.
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
JAMA|October 17, 2018
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Eclinicalmedicine|August 4, 2023
Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysisZiwen Zheng, Junfeng Huang, Ziyuan Xiang, et al.
ERJ Open Research|May 25, 2023
Improving asthma care through implementation of the SENTINEL programme: findings from the pilot siteMichael G Crooks, Lucia Crowther, Helena Cummings, et al.
The European Respiratory Journal|May 14, 2021
Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a studyAlyn Morice, Jaclyn A Smith, Lorcan McGarvey, et al.
Thorax|March 13, 2026
Aligning management of chronic cough in asthma with BTS/NICE/SIGN guidancePaul Marsden, Jaclyn Ann Smith, Surinder S Birring, et al.
Thorax|December 13, 2023
British Thoracic Society Clinical Statement on chronic cough in adultsSean M Parker, Jaclyn Ann Smith, Surinder S Birring, et al.
Lung|December 13, 2022
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic CoughLorcan McGarvey, Jaclyn A Smith, Alyn Morice, et al.
ERJ Open Research|August 5, 2021
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic coughValerie J Ludbrook, Kate E Hanrott, James L Kreindler, et al.
Breathe (Sheffield, England)|April 16, 2026
Find your career: the ERS "My Career Path" seriesSachin Ananth, Joachim Aerts, Sanjay H Chotirmall, et al.
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
JAMA|October 17, 2018
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
Pageof 5